Sonoma Pharmaceuticals (SNOA) Net Cash Flow (2010 - 2025)

Sonoma Pharmaceuticals' Net Cash Flow history runs 16 years deep, the most recent figure standing at -$601000.0 for Q4 2025.

• In Q4 2025, Net Cash Flow fell 147.29% year-over-year to -$601000.0; the TTM figure through Dec 2025 stood at -$3.4 million (down 195.3% YoY), while the FY2025 annual figure was $2.9 million, up 495.3% from the prior year.
• Net Cash Flow was -$601000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from -$707000.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $5.6 million in Q3 2021 to a low of -$2.2 million in Q3 2022.
• Historically, Net Cash Flow has averaged -$171600.0 across 5 years, with a median of -$484000.0 in 2023.
• Biggest YoY gain for Net Cash Flow was 2623.32% in 2021; the steepest drop was 1460.67% in 2021.
• A 5-year view of Net Cash Flow shows it stood at $137000.0 in 2021, then sank by 561.31% to -$632000.0 in 2022, then jumped by 133.7% to $213000.0 in 2023, then soared by 496.71% to $1.3 million in 2024, then sank by 147.29% to -$601000.0 in 2025.
• The last three Net Cash Flow figures came in at -$601000.0 (Q4 2025), -$707000.0 (Q3 2025), and -$2.2 million (Q2 2025), per Business Quant data.